Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevan

Showing results (681-690 of 2,078) with videos related to

Pageof 208
Sort By:
BMC Nephrology|November 16, 2018
The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohortMatthew J Damasiewicz, Zhong X Lu, Peter G Kerr, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2008
Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substratesJustin D Blethrow, Joseph S Glavy, David O Morgan, et al.
Nephrology (Carlton, Vic.)|February 24, 2011
Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trialNigel D Toussaint, Kenneth K Lau, Kevan R Polkinghorne, et al.
Internal Medicine Journal|August 2, 2021
Solid pancreas transplant outcomes with increased donor and recipient ages compared with reference ages: a systematic reviewJonathan E H Ling, Shi Zhou Choo, Kevan R Polkinghorne, et al.
Kidney International|October 9, 2003
Epidemiology of vascular access in the Australian hemodialysis populationKevan R Polkinghorne, Stephen P McDonald, Robert C Atkins, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
Vascular access and all-cause mortality: a propensity score analysisKevan R Polkinghorne, Stephen P McDonald, Robert C Atkins, et al.
The Journal of Clinical Investigation|September 17, 2005
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ TregsBrygida Bisikirska, John Colgan, Jeremy Luban, et al.
Journal of Affective Disorders|November 24, 2004
Electroconvulsive therapy in depressive illness that has not responded to drug treatmentSyed S Husain, Ian Mark Kevan, Rebecca Linnell, et al.
British Journal of Clinical Pharmacology|February 26, 2008
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized studyEtienne G C Brain, Kevan Rezai, François Lokiec, et al.
Annals of the New York Academy of Sciences|May 2, 2008
Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosisRavichandran Ramasamy, Shi Fang Yan, Kevan Herold, et al.
Pageof 208

Showing results (681-690 of 2,078) with videos related to

Sort By:
Pageof 208
BMC Nephrology|November 16, 2018
The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohortMatthew J Damasiewicz, Zhong X Lu, Peter G Kerr, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2008
Covalent capture of kinase-specific phosphopeptides reveals Cdk1-cyclin B substratesJustin D Blethrow, Joseph S Glavy, David O Morgan, et al.
Nephrology (Carlton, Vic.)|February 24, 2011
Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trialNigel D Toussaint, Kenneth K Lau, Kevan R Polkinghorne, et al.
Internal Medicine Journal|August 2, 2021
Solid pancreas transplant outcomes with increased donor and recipient ages compared with reference ages: a systematic reviewJonathan E H Ling, Shi Zhou Choo, Kevan R Polkinghorne, et al.
Kidney International|October 9, 2003
Epidemiology of vascular access in the Australian hemodialysis populationKevan R Polkinghorne, Stephen P McDonald, Robert C Atkins, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2004
Vascular access and all-cause mortality: a propensity score analysisKevan R Polkinghorne, Stephen P McDonald, Robert C Atkins, et al.
The Journal of Clinical Investigation|September 17, 2005
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ TregsBrygida Bisikirska, John Colgan, Jeremy Luban, et al.
Journal of Affective Disorders|November 24, 2004
Electroconvulsive therapy in depressive illness that has not responded to drug treatmentSyed S Husain, Ian Mark Kevan, Rebecca Linnell, et al.
British Journal of Clinical Pharmacology|February 26, 2008
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide according to continuous or short infusion schedules: an n = 1 randomized studyEtienne G C Brain, Kevan Rezai, François Lokiec, et al.
Annals of the New York Academy of Sciences|May 2, 2008
Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosisRavichandran Ramasamy, Shi Fang Yan, Kevan Herold, et al.
Pageof 208